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Background: Malignant mesothelioma is a rare neoplasm that generally develops in the pleural or peritoneal
cavity. Distant metastases are common; it rarely metastatizes to the head and neck region.
Case presentation: A 54-year-old white man, a non-smoker, was treated with chemotherapy, surgery and radiation
for a malignant pleural mesothelioma. Seven months after the last treatment, he developed a right submandibular
enlargement: clinical examination, ultrasound and computerized tomography scans revealed a salivary gland
hypertrophy. Anti-inflammatory and antibiotic treatment was then started, without improvement. An ultrasound
(US)-guided fine-needle aspiration biopsy (FNAB) showed atypical mesothelial cells with nuclear enlargement and
increased chromatin representation. Immunocytochemistry showed positivity for calretinin and WT-1.
A diagnosis of right submandibular salivary gland involvement from mesothelioma was established, allowing an
adequate treatment.
Conclusion: We report a very rare site of metastasis from malignant pleural mesothelioma. We suggest that
US-guided FNAB is a useful, quick, and cheap procedure for a definite diagnosis.
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Malignant mesothelioma is a rare neoplasm with an
incidence rate of 1 per 100,000 (both sexes, United
States) [1].
Approximately 80% of cases of mesothelioma develop
in the pleural cavity, whereas the other 20% arise in the
peritoneum; the pericardium is affected very rarely [2].
Metastases from malignant mesothelioma are com-
mon, usually to the local lymph nodes, pleurae of the
contralateral lung, bone, liver and brain [3]. However,
metastases to the head and neck region are uncommon
but the jaw bones, particularly the mandibular molar* Correspondence: l.cavanna@ausl.pc.it
1Department of Oncology and Hematology, Oncology Unit, Azienda
Ospedaliera ‘Guglielmo da Saliceto’, Via Taverna 49, 29100 Piacenza, Italy
Full list of author information is available at the end of the article
© 2014 Ambroggi et al.; licensee BioMed Cen
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumarea, are more likely to be the site of metastases than
the perioral region [4-19].
We present a 54-year-old man, a non-smoker, with no
occupational exposure to asbestos with malignant
pleural mesothelioma, previously treated with surgery,
radiotherapy and chemotherapy. He presented with right
submandibular salivary gland enlargement, diagnosed
using US and computerized tomography (CT) scan im-
aging techniques, as salivary gland hypertrophy, while a
fine-needle aspiration biopsy (FNAB) showed metastasis
from malignant mesothelioma.Case presentation
A 54-year-old Caucasian man underwent right pleural
biopsy in December 2005 for recurrent pleural effusion
and locally advanced malignant mesothelioma wastral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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therapy containing cisplatin and pemetrexed for seven
cycles; CT scan showed a partial response. In December
2006, he underwent surgery involving total right pleuro-
pneumonectomy plus partial resection of the pericar-
dium and diaphragm. The histological features showed
epithelioid malignant mesothelioma involving the par-
ietal and the visceral pleurae, the lung, the pericardium
and the diaphragm.
Subsequent radiotherapy to the right chest was admin-
istered using 50.4 Gy, 28 fractions.
The patient remained disease-free until June 2009
when an isoechogenic and hypodense nodule of 35 ×
16 mm was discovered on US and CT scan in the right
side of the anterior abdominal wall. An ultrasound-
guided biopsy showed metastasis of mesothelioma. In
August 2009, the nodule was surgically removed, and
radiotherapy was then administered to this site using 45
Gy, 15 fractions.
In September 2011, a relapse in the mediastinum
(lymph nodes) was found by CT scan and Positron Emis-
sion Tomography (PET), so six cycles of chemotherapy
with cisplatin and pemetrexed were started which lasted
until January 2012. Complete response at PET examin-
ation in February 2012 was demonstrated.
In November 2012, a right submandibular salivary gland
tumefaction was recorded. US examination showed right
submandibular gland hypertrophy (Figure 1), confirmed
on CT scan and with neither US nor CT signs of metasta-
sis; a diagnosis of inflammation of the gland was made.
Anti-inflammatory therapy was administered; the patient
also received antibiotic therapy but without improvement.Figure 1 Ultrasound image showing a right submandibular salivary gAn US-guided FNAB of the right submandibular salivary
gland was then performed using a 22-gauge needle and
showed atypical mesothelial cells, with nuclear enlarge-
ment and increased chromatin representation (Figure 2).
Immunocytochemistry showed positivity for calretinin
(Figure 3) and nuclear, weak and focal positivity for WT-1
(Figure 4). Based on the previous history of malignant
mesothelioma and the morphologic features of the cells,
immunocytochemistry allowed confirmation of the diag-
nosis of right submandibular involvement from epithelioid
mesothelioma. The subsequent PET scan was positive for
the right submandibular salivary gland. The patient was
treated with radiotherapy to this site.Literature review
A computerized literature search through MEDLINE,
Cancerlit and Embase was performed, in order to make a
comparison with our case, applying the words: ‘mesotheli-
oma', ‘metastasis', ‘oral cavity', ‘mouth', ‘buccal', ‘tongue',
‘head and neck area’. Articles and abstracts were also iden-
tified by back-referencing from original and relevant
papers. Selected for the present review were papers pub-
lished in English before April 2013.Conclusion
With this case report, we would like to focus on two as-
pects: 1) metastases from mesothelioma to the head and
neck area (except for lymph nodes), in particular to the
salivary glands, are very rare; 2) diagnosis of metastasis
from mesothelioma is made usually by biopsy, and not
by FNAB as in our case (Table 1).land enlargement with a low-echogenic pattern.
Figure 2 Fine-needle aspiration biopsy (FNAB) of right submandibular salivary gland shows atypical mesothelial cells with nuclear
enlargement and increased chromatin representation (A) and normal salivary gland cells ((B) acinar cells; (C) ductal cells). May-Grünwald-
Giemsa (MGG) x40.
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tastases to the head and neck area (except for lymph
nodes) from mesothelioma, but none to the salivary
glands. The most involved site was the tongue, with differ-
ent clinical presentations, followed by the mandible and in
particular the mandibular alveolus, and then the oral mu-
cosa. The clinical presentation can be of a benign
polypoid-like lesion of the tongue or a radicular cyst inFigure 3 Fine-needle aspiration biopsy (FNAB) of right submandibula
calretinin (A) and normal acinar glandular cells (B). Immunocytochemisthe mandibular alveolus, with only cyto-histological exam-
ination allowing a definite diagnosis.
The diagnosis of primary malignant mesothelioma is
established by a combination of clinical, imaging, histo-
pathological and immunohistochemical features. The
diagnosis of a secondary mesothelioma is easier and can
be made more rapidly since there is a previous diagno-
sis of the primary lesion [19]. However, even with ther salivary gland shows neoplastic mesothelial cells positive for
try, Fast red N.4.
Figure 4 Fine-needle aspiration biopsy (FNAB) of right submandibular salivary gland, showing nuclear, weak and focal,
immunocytochemically WT-1 positive mesothelioma cells (A) and normal acinar salivary gland cells (B). Immunocytochemistry, DAB.
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perform a definite diagnosis of a putative lesion to allow
appropriate management of the patient.
Reviewing the literature, in almost all cases of head
and neck metastases from mesothelioma, incisional or
excisional biopsy was performed to obtain the diagnosis;
in some cases surgical excision was needed. We found
no cases diagnosed by FNAB.
Fine-needle aspiration biopsy (FNAB) is a clinically ac-
cepted, minimally invasive technique that allows sam-
pling of tumor for diagnosis by percutaneously directing
a needle into the target lesion guided either by direct
palpation or under image guidance [20]. In general, the
accuracy, specificity and sensitivity of FNAB results de-
pend on the size of the lesion, the method of biopsy, andTable 1 Review of head and neck (except for lymph node) me
Site of metastasis Number of patients Clinical presentation
Tongue 7 Tongue lesion, nodular cons
with chronic bleeding, subm
fissure, swelling of the dorsa
polypoid lesion
Mandible 4 Radicular cyst, mandibular g
periapical radiolucency
Oral mucosa 3 Submucosal mass




We collected the previously published cases of metastases from mesothelioma to t
most frequent site of metastases, with different clinical presentations; no metastase
metastases with FNAB had been made.the histology of the tumor [21]. When FNAB is applied
as a diagnostic technique in patients with suspected ma-
lignant mesothelioma, the accuracy of diagnosis may be
low.
Though the cytologic diagnostic features of malignant
mesothelioma were described more than 50 years ago,
there is still doubt as to the ability of the cytopathologic
modality to obtain a definitive diagnosis of malignant
mesothelioma [22-24].
The published sensitivity of cytologic diagnosis of
mesothelioma ranges between 32% and 76%, and this
wide range of sensitivity is probably related to the sam-
pling technique rather than the interpretation [24].
It must be emphasized that application of immuno-
cytochemical and molecular techniques greatly enhancetastases from mesothelioma published in the literature
Diagnostic modality References
olidation of the tongue
ucosal mass, horizontal




ingival mass, Excision of the tooth,
biopsy, incisional biopsy,






he head and neck area, except for lymph node metastases. Tongue was the
s to the salivary glands had previously been found, and no diagnoses of
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nant mesothelioma [25-27]. FNAB biopsies are an ideal
method for detecting tumor relapse during the life cycle
of the cancer [28], as demonstrated in our case where
the imaging techniques of US and CT scans suggested
only salivary gland hypertrophy, while FNAB confirmed
mesothelioma relapse.
This case is interesting in that it demonstrates a rare
site of metastasis from malignant mesothelioma, and
shows the efficacy of FNAB for a definite cytologic diag-
nosis, thus allowing optimum treatment.
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